Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database

• Main Authors: Ruixue Liu (Author), Chunxiao Liu (Author), Dianwei Feng (Author), Tongxin Guo (Author), Ying Wang (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Esketamine nasal spray (ESK-NS) is a new drug for treatment-resistant depression, and we aimed to detect and characterize the adverse events (AEs) of ESK-NS using the Food and Drug Administration (FDA) adverse event reporting system (FAERS) database between 2019 Q1 and 2023 Q4. Reporting odds ratio...